HMGB1 and systemic sclerosis: Since HMGB1 was elevated in SSc patients after induced Raynaud’s attack and IP-10 was overexpressed in dermal fibroblasts treated with HMGB1, we sought whether HMGB1 (Figure 4A) and IP-10 (Figure 4B) levels are consistently elevated in SSc patients.